Improvement of individual quality of life in caregivers and patients under L-dopa/carbidopa duodenal infusion therapy

被引:0
|
作者
Ehlers, C.
Honig, H.
Odin, P.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1405
引用
收藏
页码:S541 / S542
页数:2
相关论文
共 50 条
  • [1] Treatment with Duodenal L-dopa Infusion
    Barbagli, D.
    Gusmaroli, G.
    Ravagnani, M.
    Mongiovetti, M.
    Capone, L.
    Tarletti, R.
    Massazza, U.
    Barbero, E.
    MOVEMENT DISORDERS, 2010, 25 : S718 - S718
  • [2] L-DOPA INFUSION EXPERIMENTS IN COMBINATION WITH THE L-DOPA-DECARBOXYLASE INHIBITORS BENSERAZIDE AND CARBIDOPA - L-DOPA METABOLISM AND NEUROENDOCRINOLOGICAL EFFECTS
    KAPFHAMMER, HP
    KUSS, HJ
    EBEN, E
    RUTHER, E
    PHARMACOPSYCHIATRY, 1985, 18 (01) : 143 - 144
  • [3] L-DOPA AND CARBIDOPA IN VARIANT ANGINA - INSIGHTS FOR PATHOPHYSIOLOGY AND THERAPY
    BUGIARDINI, R
    BORGHI, A
    TOLLEMETO, D
    FRANCESCHI, N
    PUDDU, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 156 - 156
  • [4] Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden
    Santos-Garcia, D.
    Anon, M. J.
    Fuster-Sanjurjo, L.
    de la Fuente-Fernandez, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (09) : 1261 - 1265
  • [5] Assessing the response to L-dopa/carbidopa intestinal gel infusion based on genetic status
    Thaler, A.
    Hillel, A.
    Shabtai, H.
    Giladi, N.
    Gurevich, T.
    MOVEMENT DISORDERS, 2017, 32
  • [6] Quality of life in Deep Brain Stimulation and Duodenal Levodopa-Carbidopa Infusion patients
    Boonpang, Kamolwan
    Kaewwilai, Lalita
    Boonrod, Nonglak
    Devahastin, Ratanaruedee
    Jandeaw, Onnalin
    Jitkritsadakul, Onanong
    Jagota, Priya
    Bhidayasiri, Roongroj
    MOVEMENT DISORDERS, 2014, 29 : S16 - S17
  • [7] Efficacy and safety of subcutaneous L-dopa/carbidopa (ND0612H) infusion in fluctuating PD patients
    Olanow, C. Warren
    Stocchi, Fabrizio
    Poewe, Werner
    Ellenbogen, Aaron
    Djaldetti, Ruth
    Minei, Tami Rachmilewitz
    Cohen, Yael
    Oren, Sheila
    Kieburtz, Karl
    NEUROLOGY, 2018, 90
  • [8] NIACIN DEPLETION IN PARKINSONIAN PATIENTS TREATED WITH L-DOPA, BENSERAZIDE AND CARBIDOPA
    BENDER, DA
    EARL, CJ
    LEES, AJ
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1979, 56 (01): : 89 - 93
  • [9] PAROSMIA AND ANOSMIA UNDER L-DOPA THERAPY
    NEUNDORFER, B
    VALDIVIESO, T
    NERVENARZT, 1977, 48 (05): : 283 - 284
  • [10] CHANGES IN TASTE UNDER L-DOPA THERAPY
    SIEGFRIED, J
    ZEITSCHRIFT FUR NEUROLOGIE, 1971, 200 (04): : 345 - +